Delivery Order SPE2DB20D3303-SPE2DB25FY9B7
Award Date
1/22/25
Potential Completion Date
1/23/25
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of XIFAXAN 550 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order with a firm fixed price of $22,755.48 and a completion date of February 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,525.09 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 13, 2024. This delivery order is part of a broader Indefinite Delivery Contract (IDC) worth $999,999,999 that AmerisourceBergen holds with...
This federal contract award is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $50,533.02 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of XIFAXAN 550 mg tablets to the Defense Logistics Agency (DLA). The $7,356.18 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 7, 2024, with a completion date of November 8, 2024. The award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $32,313.12 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 21, 2024, with a period of performance through November 22, 2024. The contract is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award is a delivery order for XIFAXAN 550 MG TABLET 60S, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $14,008.15 firm fixed-price contract has a completion date of May 22, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of XIFAXAN 550 mg tablets in 60-count bottles to the Defense Logistics Agency (DLA). The $1,903.18 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies. The award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which enables...
This federal contract award is for the delivery of XIFAXAN 550 mg tablets in quantities of 60 per bottle. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $2,907.54 and a period of performance ending on May 24, 2024. This contract is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This federal contract award is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $5,261.86, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 5, 2024. This award is not designated as a set-aside contract....
This federal contract award, valued at $11,806.49, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of January 9, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) held by...